{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T14:47:25Z","timestamp":1792162045525,"version":"4.4.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100012043","name":"Kindai University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012043","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-026-04587-z","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T14:08:35Z","timestamp":1792159715000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Higher TIGIT expression in the intraperitoneal immune microenvironment is associated with shorter progression-free survival in patients with gastric cancer with peritoneal metastasis treated with intraperitoneal paclitaxel"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-6384-2836","authenticated-orcid":false,"given":"Atsushi","family":"Yamada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2242-4245","authenticated-orcid":false,"given":"Motohiro","family":"Imano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryusuke","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Kounami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masuhiro","family":"Terada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Kohda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoya","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Hiraki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Shiraishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Shinkai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takushi","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,16]]},"reference":[{"issue":"3","key":"4587_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. CA Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin."},{"key":"4587_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15061777","author":"I Manzanedo","year":"2023","unstructured":"Manzanedo I, Pereira F, Perez-Viejo E, Serrano A. Gastric cancer with peritoneal metastases: current status and prospects for treatment. Cancers (Basel). 2023. https:\/\/doi.org\/10.3390\/cancers15061777.","journal-title":"Cancers (Basel)"},{"issue":"20","key":"4587_CR3","doi-asserted-by":"publisher","first-page":"3247","DOI":"10.12998\/wjcc.v7.i20.3247","volume":"7","author":"LN Zheng","year":"2019","unstructured":"Zheng LN, Wen F, Xu P, Zhang S. Prognostic significance of malignant ascites in gastric cancer patients with peritoneal metastasis: a systemic review and meta-analysis. World J Clin Cases. 2019;7(20):3247\u201358. https:\/\/doi.org\/10.12998\/wjcc.v7.i20.3247.","journal-title":"World J Clin Cases"},{"issue":"2","key":"4587_CR4","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/ags3.12060","volume":"2","author":"J Kitayama","year":"2018","unstructured":"Kitayama J, Ishigami H, Yamaguchi H, Sakuma Y, Horie H, Hosoya Y, et al. Treatment of patients with peritoneal metastases from gastric cancer. Ann Gastroenterol Surg. 2018;2(2):116\u201323. https:\/\/doi.org\/10.1002\/ags3.12060.","journal-title":"Ann Gastroenterol Surg"},{"issue":"10294","key":"4587_CR5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0140-6736(21)00797-2","volume":"398","author":"YY Janjigian","year":"2021","unstructured":"Janjigian YY, Shitara K, Moehler M, Garrido M, Salman P, Shen L, et al. First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial. Lancet. 2021;398(10294):27\u201340. https:\/\/doi.org\/10.1016\/S0140-6736(21)00797-2.","journal-title":"Lancet"},{"issue":"2","key":"4587_CR6","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/S1470-2045(21)00692-6","volume":"23","author":"YK Kang","year":"2022","unstructured":"Kang YK, Chen LT, Ryu MH, Oh DY, Oh SC, Chung HC, et al. Nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastro-oesophageal junction cancer (ATTRACTION-4): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol. 2022;23(2):234\u201347. https:\/\/doi.org\/10.1016\/S1470-2045(21)00692-6.","journal-title":"Lancet Oncol"},{"issue":"6","key":"4587_CR7","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1007\/s10120-024-01535-0","volume":"27","author":"N Boku","year":"2024","unstructured":"Boku N, Omori T, Shitara K, Sakuramoto S, Yamaguchi K, Kato K, et al. Gastric Cancer. 2024;27(6):1287\u2013301. https:\/\/doi.org\/10.1007\/s10120-024-01535-0.","journal-title":"Gastric Cancer."},{"issue":"4","key":"4587_CR8","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1159\/000333803","volume":"47","author":"M Imano","year":"2011","unstructured":"Imano M, Imamoto H, Itoh T, Satou T, Peng YF, Yasuda A, et al. Eur Surg Res. 2011;47(4):254\u20139. https:\/\/doi.org\/10.1159\/000333803.","journal-title":"Eur Surg Res."},{"issue":"12","key":"4587_CR9","first-page":"1355","volume":"44","author":"M Shinkai","year":"2017","unstructured":"Shinkai M, Imano M, Hiraki Y, Kato H, Iwama M, Shiraishi O, et al. Simplified percutaneous endoscopic transgastric conduit feeding jejunostomy for dysphagia after esophagectomy. Gan To Kagaku Ryoho. 2017;44(12):1355\u20137.","journal-title":"Gan To Kagaku Ryoho"},{"issue":"1","key":"4587_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-27936-4","volume":"15","author":"T Nakanishi","year":"2025","unstructured":"Nakanishi T, Imano M, Kohda M, Kato H, Kounami N, Yamada A, et al. Intraperitoneal immune microenvironment and efficacy of intraperitoneal chemotherapy in patients with gastric cancer and peritoneal metastasis. Sci Rep. 2025;15(1):44193. https:\/\/doi.org\/10.1038\/s41598-025-27936-4.","journal-title":"Sci Rep"},{"issue":"2","key":"4587_CR11","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.immuni.2024.01.010","volume":"57","author":"N Joller","year":"2024","unstructured":"Joller N, Anderson AC, Kuchroo VK. Immunity. 2024;57(2):206\u201322. https:\/\/doi.org\/10.1016\/j.immuni.2024.01.010.","journal-title":"Immunity."},{"issue":"22","key":"4587_CR12","doi-asserted-by":"publisher","first-page":"6375","DOI":"10.1158\/0008-5472.CAN-17-0381","volume":"77","author":"W He","year":"2017","unstructured":"He W, Zhang H, Han F, Chen X, Lin R, Wang W, et al. Cancer Res. 2017;77(22):6375\u201388. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-0381.","journal-title":"Cancer Res."},{"issue":"4","key":"4587_CR13","doi-asserted-by":"publisher","first-page":"605","DOI":"10.5230\/jgc.2025.25.e46","volume":"25","author":"H Kim","year":"2025","unstructured":"Kim H, Kwon M, Lee SK, Son SM, Lee OJ, Man Yoon S, et al. J Gastric Cancer. 2025;25(4):605\u201320. https:\/\/doi.org\/10.5230\/jgc.2025.25.e46.","journal-title":"J Gastric Cancer."},{"key":"4587_CR14","volume-title":"Japanese classification of gastric carcinoma","author":"Japanese Gastric Cancer Association","year":"2026","unstructured":"Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma. 16th ed. Tokyo: Kanehara Shuppan; 2026.","edition":"16th ed"},{"issue":"6","key":"4587_CR15","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1007\/s004230050246","volume":"384","author":"PH Sugarbaker","year":"1999","unstructured":"Sugarbaker PH. Langenbecks Arch Surg. 1999;384(6):576\u201387. https:\/\/doi.org\/10.1007\/s004230050246.","journal-title":"Langenbecks Arch Surg."},{"key":"4587_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10235666","author":"H Ishigami","year":"2021","unstructured":"Ishigami H, Tsuji Y, Shinohara H, Kodera Y, Kanda M, Yabusaki H, et al. Intraperitoneal chemotherapy as adjuvant or perioperative chemotherapy for patients with type 4 scirrhous gastric cancer: PHOENIX-GC2 trial. J Clin Med. 2021. https:\/\/doi.org\/10.3390\/jcm10235666.","journal-title":"J Clin Med"},{"issue":"12","key":"4587_CR17","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1007\/s11605-012-2059-3","volume":"16","author":"M Imano","year":"2012","unstructured":"Imano M, Yasuda A, Itoh T, Satou T, Peng YF, Kato H, et al. J Gastrointest Surg. 2012;16(12):2190\u20136. https:\/\/doi.org\/10.1007\/s11605-012-2059-3.","journal-title":"J Gastrointest Surg."},{"issue":"6","key":"4587_CR18","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1002\/ags3.12386","volume":"4","author":"M Honda","year":"2020","unstructured":"Honda M, Kawamura H, Kobayashi H, Takiguchi K, Muto A, Yamazaki S, et al. An ascites grading system for predicting the prognosis of gastric cancer with peritoneum dissemination. Ann Gastroenterol Surg. 2020;4(6):660\u20136. https:\/\/doi.org\/10.1002\/ags3.12386.","journal-title":"Ann Gastroenterol Surg"},{"issue":"26","key":"4587_CR19","doi-asserted-by":"publisher","first-page":"5879","DOI":"10.3748\/wjg.v22.i26.5879","volume":"22","author":"F Grillo","year":"2016","unstructured":"Grillo F, Fassan M, Sarocchi F, Fiocca R, Mastracci L. World J Gastroenterol. 2016;22(26):5879\u201387. https:\/\/doi.org\/10.3748\/wjg.v22.i26.5879.","journal-title":"World J Gastroenterol."},{"issue":"4","key":"4587_CR20","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s10120-025-01609-7","volume":"28","author":"V Angerilli","year":"2025","unstructured":"Angerilli V, Callegarin M, Govoni I, De Lisi G, Paudice M, Fugazzola P, et al. Gastric Cancer. 2025;28(4):569\u201378. https:\/\/doi.org\/10.1007\/s10120-025-01609-7.","journal-title":"Gastric Cancer."},{"issue":"5","key":"4587_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/cnr2.1389","volume":"4","author":"T Yamaguchi","year":"2021","unstructured":"Yamaguchi T, Kinoshita J, Saito H, Shimada M, Terai S, Moriyama H, et al. Cancer Rep (Hoboken). 2021;4(5):e1389. https:\/\/doi.org\/10.1002\/cnr2.1389.","journal-title":"Cancer Rep (Hoboken)."},{"key":"4587_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.969468","volume":"13","author":"K Takahashi","year":"2022","unstructured":"Takahashi K, Kurashina K, Yamaguchi H, Kanamaru R, Ohzawa H, Miyato H, et al. Front Immunol. 2022;13:969468. https:\/\/doi.org\/10.3389\/fimmu.2022.969468.","journal-title":"Front Immunol."},{"issue":"1","key":"4587_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-023-01499-1","volume":"16","author":"L Cai","year":"2023","unstructured":"Cai L, Li Y, Tan J, Xu L, Li Y. Targeting LAG-3, TIM-3, and TIGIT for cancer immunotherapy. J Hematol Oncol. 2023;16(1):101. https:\/\/doi.org\/10.1186\/s13045-023-01499-1.","journal-title":"J Hematol Oncol"},{"issue":"5","key":"4587_CR24","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.immuni.2016.05.001","volume":"44","author":"AC Anderson","year":"2016","unstructured":"Anderson AC, Joller N, Kuchroo VK. Immunity. 2016;44(5):989\u20131004. https:\/\/doi.org\/10.1016\/j.immuni.2016.05.001.","journal-title":"Immunity."},{"issue":"4","key":"4587_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0152982","volume":"11","author":"A Iguchi-Manaka","year":"2016","unstructured":"Iguchi-Manaka A, Okumura G, Kojima H, Cho Y, Hirochika R, Bando H, et al. PLoS One. 2016;11(4):e0152982. https:\/\/doi.org\/10.1371\/journal.pone.0152982.","journal-title":"PLoS One."},{"issue":"3","key":"4587_CR26","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1073\/pnas.77.3.1561","volume":"77","author":"PB Schiff","year":"1980","unstructured":"Schiff PB, Horwitz SB. Taxol stabilizes microtubules in mouse fibroblast cells. Proc Natl Acad Sci U S A. 1980;77(3):1561\u20135. https:\/\/doi.org\/10.1073\/pnas.77.3.1561.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"41","key":"4587_CR27","doi-asserted-by":"publisher","first-page":"17218","DOI":"10.1039\/d1nr05512g","volume":"13","author":"M Jiang","year":"2021","unstructured":"Jiang M, Zeng J, Zhao L, Zhang M, Ma J, Guan X, et al. Chemotherapeutic drug-induced immunogenic cell death for nanomedicine-based cancer chemo\u2013immunotherapy. Nanoscale. 2021;13(41):17218\u201335. https:\/\/doi.org\/10.1039\/d1nr05512g.","journal-title":"Nanoscale"},{"issue":"3","key":"4587_CR28","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1053\/ejso.2002.1397","volume":"29","author":"F Mohamed","year":"2003","unstructured":"Mohamed F, Marchettini P, Stuart OA, Yoo D, Sugarbaker PH. A comparison of hetastarch and peritoneal dialysis solution for intraperitoneal chemotherapy delivery. Eur J Surg Oncol. 2003;29(3):261\u20135. https:\/\/doi.org\/10.1053\/ejso.2002.1397.","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"4587_CR29","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s10388-024-01105-4","volume":"22","author":"CH Chuang","year":"2025","unstructured":"Chuang CH, Guo JC, Kato K, Hsu CH. Esophagus. 2025;22(2):139\u201347. https:\/\/doi.org\/10.1007\/s10388-024-01105-4.","journal-title":"Esophagus."},{"issue":"1","key":"4587_CR30","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/s1470-2045(25)00401-2","volume":"27","author":"CH Hsu","year":"2026","unstructured":"Hsu CH, Lu Z, Gao S, Wang J, Sun JM, Liu T, et al. Tiragolumab plus atezolizumab and chemotherapy as first-line treatment for patients with unresectable oesophageal squamous cell carcinoma (SKYSCRAPER-08): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol. 2026;27(1):103\u201315. https:\/\/doi.org\/10.1016\/s1470-2045(25)00401-2.","journal-title":"Lancet Oncol"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04587-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-026-04587-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04587-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T14:08:36Z","timestamp":1792159716000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-026-04587-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,16]]},"references-count":30,"alternative-id":["4587"],"URL":"https:\/\/doi.org\/10.1007\/s12094-026-04587-z","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,16]]},"assertion":[{"value":"27 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest for this article.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval of the research protocol by an Institutional Reviewer Board: This study was approved by the Ethics Committee of Kindai University Faculty of Medicine (Approval No. 31-182) and conforms to the provisions of the Declaration of Helsinki.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":3,"name":"Ethics","label":"Animal studies","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Because this was a retrospective study, patients had previously provided comprehensive written consent at the time of treatment for the future research use of their clinical data and biological samples. This comprehensive consent was obtained under the same institutional review board approval that covered the present retrospective analysis.","order":4,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}